Health
EBMT trial shows improvements in treatment of Severe Aplastic Anaemia – Science Codex
The European Society for Blood and Marrow Transplantation (EBMT), Europe’s collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of the phase III RACE trial during EBMTs virtual 46th Annual Meeting. Preliminary data show that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in patients with Severe Aplastic Anaemia (SAA).
SAA is a condition in which the bone m…
-
Noosa News18 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Business23 hours agoAre BHP shares are buy after its results?
-
Noosa News24 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Noosa News10 hours agoItalian Film Festival, Brisbane: All the Details